NCT02391025View on ClinicalTrials.gov

Gallium-68 Citrate PET Used in Prostate Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 28, 2015

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Prostatic Neoplasms
Interventions
DRUG

Gallium-68 citrate

Given via IV at time of imaging

PROCEDURE

Positron Emission Tomography (PET)

Imaging procedure

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Rahul Aggarwal

OTHER

NCT02391025 - Gallium-68 Citrate PET Used in Prostate Cancer | Biotech Hunter | Biotech Hunter